Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tetsuo NAKAMURA
Orally Administrated Risedronate Can Commit V.GAMMA.2V.DELTA.2 T Cells to IFN-.GAMMA. Secreting Effectors in Patients With Osteoporosis
Biomedical Research
Biochemistry
Medicine
Genetics
Molecular Biology
Related publications
.GAMMA..DELTA. T Lymphocytes and Their V.GAMMA.9 and V.DELTA.2 Receptor Expression in Peripheral Blood Mononuclear Cells of Active Tuberculosis Patients Before and After Treatment.
Kurume Medical Journal
Medicine
Non-V Delta 2 Gamma Delta T Lymphocytes as Effectors of Cancer Immunotherapy
OncoImmunology
Oncology
Allergy
Immunology
Human TH17 Immune Cells Specific for the Tumor Antigen MAGE-A3 Convert to IFN- -Secreting Cells as They Differentiate Into Effector T Cells in Vivo
Cancer Research
Cancer Research
Oncology
Risedronate Therapy for the Prevention of Steroid-Induced Osteoporosis in Patients With Minimal-Change Nephrotic Syndrome
Internal Medicine
Internal Medicine
Medicine
Crystal Structures of the Osteoporosis Drug Risedronate
Acta Crystallographica Section A Foundations of Crystallography
Monthly Risedronate for the Treatment of Postmenopausal Osteoporosis
Pharmaceutica Analytica Acta
Transparency : Can Central Banks Commit to Truthful Communication?
Cost-Effectiveness of Teriparatide Compared With Alendronate and Risedronate for the Treatment of Postmenopausal Osteoporosis Patients in Iran
Medical Journal of the Islamic Republic of Iran
Medicine
Orally Administrated Dipeptide Ser-Tyr Efficiently Stimulates Noradrenergic Turnover in the Mouse Brain
Bioscience, Biotechnology and Biochemistry
Organic Chemistry
Applied Microbiology
Molecular Biology
Biochemistry
Analytical Chemistry
Medicine
Biotechnology
